Savolitinib vs. Sunitinib in MET-driven PRCC.
AstraZeneca
AstraZeneca
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
University of Alabama at Birmingham
University of Waterloo
University of Michigan
University of Waterloo
Columbia University
Pfizer
Stanford University
Merck Sharp & Dohme LLC
Fenwal, Inc.
M.D. Anderson Cancer Center